The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Brevibloc Premixed 10 mg/ml Solution for Injection

Baxter Holding B.V.PA2299/021/001

Main Information

Trade NameBrevibloc Premixed 10 mg/ml Solution for Injection
Active SubstancesEsmolol Hydrochloride
Dosage FormSolution for injection
Licence HolderBaxter Holding B.V.
Licence NumberPA2299/021/001

Group Information

ATC CodeC07AB Beta blocking agents, selective
C07AB09 esmolol


License statusAuthorised
Licence Issued10/12/2010
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back